Explore
Premium
Sign Up
Log In
CRT 2017 : FDA Town Hall - Medtech in Transition: Where are we now and what lies ahead?
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
FDA Town Hall - Medtech in Transition: Where are we now and what lies ahead?
Featuring
Jeffrey Shuren
Mitchell Sugarman
Deepak Nath
Stuart Seides
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
State of CDRH 2017 and Future Directions - Jeffrey Shuren
State of Coverage With Evidence Development in 2017 and Future Directions - Mitchell Sugarman
State of the Industry - Deepak Nath
State of the Integrated Medical Center System - Stuart Seides
Target Audience
Learning Objectives
Related Moments
Percutaneous Treatment Of Coronary Chronic Total Occlusions Part 1: Rationale And Outcomes
Journal
Article on Percutaneous Treatment Of Coronary Chronic Total Occlusions Part 1: Rationale And Outcomes
The FUTURE Study - Scientific Review
Roundtable
FUTURE is a French open label, randomized clinical trial designed to test the superiority of FFR against angiography guided revascularization. Some of the early outcomes of the study were reported...
Supported By
CRT 2015 Technology & Innovation - Session III: Best Evaluation for Renal Denervation - Same or Different in Japan and USA?
Conference
Session III: Best Evaluation for Renal Denervation - Same or Different in Japan and USA? from CRT 2015
Loading Simple Education
